Streetbeat News

Analyst Ratings

LVS

A significant bearish stance has been taken on Las Vegas Sands (NYSE:LVS) by a large investor, as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 46% bullish and 53% bearish. The whales have been targeting a price range from $35.0 to $67.5 for Las Vegas Sands over the last 3 months. Jefferies has downgraded its action to Hold with a price target of $65, while JP Morgan maintains their Overweight rating with a price target of $72.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 7:15 pm

NKE

QQQ

SPY

TSLA

Benzinga's AI-powered portfolio, managed by OpenAI's ChatGPT, slipped from seventh to fifth place in the eighth week of a six-month experiment comparing its performance against 10 leading U.S. equity funds. The portfolio, which started with a hypothetical $10,000, is currently up 8.6% over seven weeks. Tesla Inc (TSLA) continues to be the star performer in the portfolio, up 65.46% since the position was taken, while Nike Inc (NKE) is the biggest loser, down 8.75%.

Portfolio Pulse from AJ Fabino

July 05, 2023 | 7:15 pm

SF

Stifel has released a note stating that Rivada has received a waiver from the International Telecommunication Union (ITU) for its Low Earth Orbit (LEO) constellation. This allows Rivada to proceed with its second milestone of deploying 300 satellites.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 7:09 pm

GLPI

In the last quarter, Gaming and Leisure Props (NASDAQ:GLPI) received six somewhat bullish ratings and one indifferent rating from analysts. The average price target is $56.71, indicating an upside from the current price of $48.48. However, this average has decreased by 5.48% from the previous average price target of $60.00.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 7:01 pm

SHW

Sherwin-Williams (NYSE:SHW) has received various analyst ratings in the last quarter, with 5 bullish, 2 somewhat bullish, and 5 indifferent. The average price target is $268.5, compared to its current price of $259.835, implying an upside. The average price target has increased by 7.21% over the past month.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 7:01 pm

VICI

VICI Props (NYSE:VICI) has received three somewhat bullish ratings, one indifferent rating, and no bearish ratings from analysts in the last quarter. The average 12-month price target for the stock is $37.75, representing a 1.95% decrease from the previous average price target of $38.50.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 7:00 pm

NDLS

Analysts have provided various ratings for Noodles (NASDAQ:NDLS) within the last quarter, with 2 bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target for Noodles is $6.5, representing an 18.75% decrease from the previous average price target of $8.00.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 7:00 pm

AXTA

In the last quarter, Axalta Coating Sys (NYSE:AXTA) received 3 bullish, 1 somewhat bullish, 2 indifferent, and 1 somewhat bearish ratings from analysts. The average price target is $33.86, indicating an upside from the current price of $32.165. This average has increased by 12.87% from the previous target of $30.00.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 7:00 pm

GBX

KeyBanc Capital Markets analyst Steve Barger reiterated the Sector Weight rating on Greenbrier Companies (NYSE:GBX), following a strong 3Q report and a solid preliminary 4Q order book. Barger expects more orders for GBX as the quarter progresses, reversing the trend of backlog declines. The analyst is also optimistic about easing supply chain constraints and cost-saving initiatives contributing to margin expansion. Barger raised EPS estimates for FY23, FY24, and FY25, and remains optimistic about GBX's progress towards its cost optimization goal.

Portfolio Pulse from Nabaparna Bhattacharya

July 05, 2023 | 6:59 pm

DXCM

DexCom Inc.'s stock has increased by 6.75% over the past month and by 55.82% over the past year. The company's P/E ratio of 178.9 is higher than the Health Care Equipment & Supplies industry average of 153.77, suggesting that the stock might be overvalued. However, the P/E ratio should not be used in isolation for investment decisions, as other factors such as industry trends and business cycles can also impact a company's stock price.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 6:51 pm